Literature DB >> 18026683

Evolution of vertebrate indoleamine 2,3-dioxygenases.

Hajime Julie Yuasa1, Miwa Takubo, Ayumi Takahashi, Tetsuo Hasegawa, Hiroshi Noma, Tomohiko Suzuki.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) are tryptophan-degrading enzymes that catalyze the same reaction, the first step in tryptophan catabolism via the kynurenine pathway. TDO is widely distributed among life-forms, being found not only in eukaryotes but also in bacteria. In contrast, IDO has been found only in mammals and yeast to date. However, recent genome and EST projects have identified IDO homologues in non-mammals and found an IDO paralogue that is expressed in mice. In this study, we cloned the frog and fish IDO homologues and the mouse IDO paralogue, and characterized their enzymatic properties using recombinants. The IDOs of lower vertebrates and the mouse IDO paralogue had IDO activity but had 500-1000 times higher K(m) values and very low enzyme efficiency compared with mammalian IDOs. It appears that L-Trp is not a true substrate for these enzymes in vivo, although their actual function is unknown. On the phylogenetic tree, these low-activity IDOs, which we have named "proto-IDOs," formed a cluster that was distinct from the mammalian IDO cluster. The IDO and proto-IDO genes are present tandemly on the chromosomes of mammals, including the marsupial opossum, whereas only the proto-IDO gene is observed in chicken and fish genomes. These results suggest that (mammalian) IDOs arose from proto-IDOs by gene duplication that occurred before the divergence of marsupial and eutherian (placental) mammals in mammalian evolutionary history.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026683     DOI: 10.1007/s00239-007-9049-1

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  30 in total

1.  Heme-Containing Oxygenases.

Authors:  Masanori Sono; Mark P. Roach; Eric D. Coulter; John H. Dawson
Journal:  Chem Rev       Date:  1996-11-07       Impact factor: 60.622

2.  The order of sequence alignment can bias the selection of tree topology.

Authors:  J A Lake
Journal:  Mol Biol Evol       Date:  1991-05       Impact factor: 16.240

3.  Cytochrome b(5) is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast.

Authors:  Eduardo Vottero; David A Mitchell; Michael J Page; Ross T A MacGillivray; Ivan J Sadowski; Michel Roberge; A Grant Mauk
Journal:  FEBS Lett       Date:  2006-03-20       Impact factor: 4.124

4.  Cloning and characterization of the Tribolium castaneum eye-color genes encoding tryptophan oxygenase and kynurenine 3-monooxygenase.

Authors:  Marcé D Lorenzen; Susan J Brown; Robin E Denell; Richard W Beeman
Journal:  Genetics       Date:  2002-01       Impact factor: 4.562

Review 5.  Evolution of myoglobin.

Authors:  T Suzuki; K Imai
Journal:  Cell Mol Life Sci       Date:  1998-09       Impact factor: 9.261

Review 6.  A myoglobin evolved from indoleamine 2,3-dioxygenase, a tryptophan-degrading enzyme.

Authors:  T Suzuki; H Kawamichi; K Imai
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1998-10       Impact factor: 2.231

7.  The Tryptophan oxygenase gene of Anopheles gambiae.

Authors:  O Mukabayire; A J Cornel; E M Dotson; F H Collins; N J Besansky
Journal:  Insect Biochem Mol Biol       Date:  1996-06       Impact factor: 4.714

Review 8.  The human indoleamine 2,3-dioxygenase gene and related human genes.

Authors:  Michael F Murray
Journal:  Curr Drug Metab       Date:  2007-04       Impact factor: 3.731

9.  Do molluscs possess indoleamine 2,3-dioxygenase?

Authors:  Hajime Julie Yuasa; Tomohiko Suzuki
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2005-03       Impact factor: 2.231

10.  A myoglobin evolved from indoleamine 2,3-dioxygenase.

Authors:  T Suzuki; T Takagi
Journal:  J Mol Biol       Date:  1992-11-20       Impact factor: 5.469

View more
  41 in total

Review 1.  Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells.

Authors:  Ryan G Gaudet; Clinton J Bradfield; John D MacMicking
Journal:  Microbiol Spectr       Date:  2016-12

2.  Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.

Authors:  Paul B Larkin; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Hiroshi Funakoshi; Toshikazu Nakamura; Robert Schwarcz; Paul J Muchowski
Journal:  Biochim Biophys Acta       Date:  2016-07-05

Review 3.  The role of placental tryptophan catabolism.

Authors:  Peter Sedlmayr; Astrid Blaschitz; Roland Stocker
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

4.  Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.

Authors:  Hajime J Yuasa; Helen J Ball
Journal:  J Mol Evol       Date:  2010-12-18       Impact factor: 2.395

5.  IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.

Authors:  Lauren M F Merlo; Elizabeth Pigott; James B DuHadaway; Samantha Grabler; Richard Metz; George C Prendergast; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

Review 6.  The nocturnal bottleneck and the evolution of activity patterns in mammals.

Authors:  Menno P Gerkema; Wayne I L Davies; Russell G Foster; Michael Menaker; Roelof A Hut
Journal:  Proc Biol Sci       Date:  2013-07-03       Impact factor: 5.349

Review 7.  Placental expression of indoleamine 2,3-dioxygenase.

Authors:  Peter Sedlmayr; Astrid Blaschitz
Journal:  Wien Med Wochenschr       Date:  2012-05

Review 8.  Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.

Authors:  Ciriana Orabona; Maria Teresa Pallotta; Ursula Grohmann
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

9.  Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.

Authors:  Carlos R Dostal; Nicolaus S Gamsby; Marcus A Lawson; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2017-12-11       Impact factor: 7.217

10.  Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.

Authors:  Esther Jortzik; Kathleen Zocher; Antje Isernhagen; Boniface M Mailu; Stefan Rahlfs; Giampietro Viola; Sergio Wittlin; Nicholas H Hunt; Heiko Ihmels; Katja Becker
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.